UnknownPhase 4NCT01987297

Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL

Studying Acute promyelocytic leukemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shanghai Jiao Tong University School of Medicine
Principal Investigator
Jun-min Li, M.D
Department of Hematology, Rui Jin Hospital, Shanghai JiaoTong University School of Medicine
Intervention
ATRA+Arsenic(drug)
Enrollment
738 enrolled
Eligibility
18-65 years · All sexes
Timeline
2012 – 2020

Study locations (1)

Collaborators

Tang-Du Hospital · Peking University People's Hospital · First Affiliated Hospital of Zhejiang University · Tongji Hospital · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · First Hospital of China Medical University · Southwest Hospital, China · West China Hospital · Ningbo No. 1 Hospital · Qilu Hospital of Shandong University · Shandong Provincial Hospital · Union hospital of Fujian Medical University · First Affiliated Hospital of Guangxi Medical University · Guangdong Provincial People's Hospital · First Affiliated Hospital, Sun Yat-Sen University · The First Affiliated Hospital of Soochow University · The First Affiliated Hospital with Nanjing Medical University · The Second Affiliated Hospital of Dalian Medical University · Nanfang Hospital, Southern Medical University · The First Affiliated Hospital of Anhui Medical University · Institute of Hematology & Blood Diseases Hospital, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01987297 on ClinicalTrials.gov

Other trials for Acute promyelocytic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute promyelocytic leukemia →

← Back to all trials